Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy is not a steroid. It contains semaglutide, a synthetic version of a hormone your gut produces naturally called GLP-1 (glucagon-like peptide-1). It has no structural, chemical or functional relationship to anabolic steroids or corticosteroids. Wegovy works by slowing how quickly your stomach empties and reducing appetite signals in the brain — a completely different mechanism from any steroid class. It is a prescription-only medicine for weight management in adults, requiring clinical assessment before a prescriber decides whether it is suitable. The confusion is understandable: Wegovy made headlines quickly, and when something produces significant results, people reasonably wonder whether something stronger or more unusual is at play. It is not. The NHS medicines page for semaglutide explains its action clearly if you want the full clinical picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When a weight-loss medicine produces average reductions of around 15% of body weight over 68 weeks (as semaglutide 2.4mg did in the STEP 1 trial, published in the New England Journal of Medicine) people look for an explanation that matches the scale of the result. Steroids are the shorthand many people reach for when results seem dramatic. It is a logical leap, and it is wrong.
Anabolic steroids are synthetic versions of testosterone; they build muscle and are associated with performance-enhancing use. Corticosteroids (like prednisolone or dexamethasone) are anti-inflammatory medicines that mimic cortisol. Both groups act on steroid receptors inside cells and affect a wide range of biological processes, including, paradoxically, some that promote weight gain rather than loss, particularly with long-term corticosteroid use.
Semaglutide belongs to a completely separate drug class, and our page on steroids and semaglutide goes into detail about exactly why these two categories of medicine are so different. It is a GLP-1 receptor agonist: a peptide that binds to receptors on cells in your gut, pancreas and brain. Its effects on weight come from slowing gastric emptying (food sits in your stomach longer, so you feel full sooner) and reducing appetite signals reaching the brain. No steroid does either of those things. The two drug families do not overlap.
Your body already makes GLP-1 naturally, released from cells in the small intestine after you eat. It tells the pancreas to release insulin, slows the passage of food and sends fullness signals upward. In people living with obesity, this system often does not function with full efficiency. Semaglutide is a lab-made analogue of GLP-1 that is modified to last much longer in the body than the natural hormone, a weekly injection, rather than the seconds the natural version survives.
This is why its side-effect profile looks nothing like a steroid's. The most common effects are gastrointestinal: nausea, changes in bowel habit, indigestion. These tend to be most noticeable at the start of treatment or after a dose increase, and they commonly ease within the first couple of weeks. You will not find the muscle changes, mood swings or hormonal disruption that steroid use produces. The mechanisms are simply different. If questions about how it interacts with other hormones are on your mind, our page on progesterone and Wegovy covers that specific interaction in detail.
Wegovy carries a Black Triangle (▼) designation from the MHRA, meaning it is subject to additional monitoring as a relatively new medicine. That is a layer of ongoing safety oversight, not a reason for alarm, it reflects standard practice for medicines approved in the last few years.
Anabolic steroids are well known for disrupting lipid profiles, typically raising LDL cholesterol and lowering HDL. People sometimes ask whether Wegovy does something similar, which is another route this steroid question travels.
The evidence points in the opposite direction. Clinical trials have observed improvements in lipid profiles alongside weight loss in participants taking semaglutide, and cardiovascular outcome data for Wegovy has been broadly positive. Our page on Wegovy and cholesterol covers what the evidence shows in detail. The short answer: the direction of effect on cholesterol is not comparable to anabolic steroid use.
Blood pressure, blood sugar regulation and liver fat have also shown improvements in trial participants, effects consistent with sustained weight reduction rather than anything a steroid would produce. If you are already taking steroids for another condition and wondering whether that changes things, our dedicated page on whether you can take steroids with semaglutide addresses that question directly. Worth knowing if you were concerned the two might behave similarly.
Wegovy is a Prescription-Only Medicine. In practice, that means you cannot obtain it legally without a prescription following a proper clinical assessment. A prescriber reviews your health history, current medicines and BMI before deciding whether it is appropriate for you.
If you are considering treatment, understanding what you are taking matters. Our Wegovy overview covers the licensed uses, the titration schedule and the eligibility criteria clearly. For context on what private treatment costs and what is included in a legitimate service, the Wegovy prices page is worth reading before you compare providers.
At nume, every consultation is read by a GPhC-registered Independent Prescriber, a real clinician, not automated screening. Our clinical team can also be explored on our about us page if you want to understand who reviews your information. Medicines sourced outside the regulated UK supply chain carry real risks, including counterfeit products that the MHRA has flagged publicly, the Yellow Card scheme allows anyone to report a suspect product or seller.
If you have specific questions or want to explore whether Wegovy is clinically suitable for you, start your free consultation and a prescriber will review your information the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.